Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (855)
2023 (887)
2022 (831)
2021 (892)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (245)
2011 (163)
2010 (139)
2000 (2)
1977 (2)
All (8503)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
Klingström J
JSON
CSV
XLSX
TXT
Family name
Klingström
Given name
Jonas
Initials
J
ORCID
ORCID
0000-0001-9076-1441
Affiliations
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
16 publications
PubMed
DOI
Crossref
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.
Bladh O, Greilert-Norin N,
Havervall S
, ...,
Klingström J
, Thålin C
N. Engl. J. Med.
389
(17) 1626-1628 [2023-10-26; online 2023-10-27]
Affinity Proteomics Uppsala [Collaborative]
PubMed
DOI
Crossref
Comprehensive proteomics and meta-analysis of COVID-19 host response.
Babačić H
,
Christ W
, Araújo JE, ...,
Klingström J
,
Pernemalm M
Nat Commun
14
(1) 5921 [2023-09-22; online 2023-09-22]
Global Proteomics and Proteogenomics [Collaborative]
PubMed
DOI
Crossref
Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19.
Yu M
,
Charles A
, Cagigi A, ...,
Loré K
,
Smed-Sörensen A
Nat Commun
14
(1) 2164 [2023-04-15; online 2023-04-15]
Bioinformatics Long-term Support WABI [Collaborative]
Bioinformatics Support, Infrastructure and Training [Collaborative]
PubMed
DOI
Crossref
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers.
Marking U, Havervall S, Norin NG, ...,
Klingström J
, Thålin C
Nat Commun
14
(1) 1577 [2023-03-22; online 2023-03-22]
Affinity Proteomics Uppsala [Collaborative]
Autoimmunity and Serology Profiling [Collaborative]
PubMed
DOI
Crossref
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.
Havervall S
, Marking U, Svensson J, ..., Smed-Sörensen A, Thålin C
N. Engl. J. Med.
387
(14) 1333-1336 [2022-10-06; online 2022-09-14]
Affinity Proteomics Uppsala [Collaborative]
Autoimmunity and Serology Profiling [Collaborative]
PubMed
DOI
Crossref
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time.
Havervall S
, Marking U, Greilert-Norin N, ..., Åberg M, Thålin C
Clin Transl Immunology
11
(4) e1388 [2022-04-18; online 2022-04-18]
Affinity Proteomics Uppsala [Collaborative]
Autoimmunity and Serology Profiling [Collaborative]
PubMed
DOI
Crossref
Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
Kaku CI
, Champney ER,
Normark J
, ...,
Forsell MNE
,
Walker LM
Science
375
(6584) 1041-1047 [2022-03-04; online 2022-02-10]
Autoimmunity and Serology Profiling [Collaborative]
PubMed
DOI
Crossref
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.
Marking U,
Havervall S
, Greilert-Norin N, ..., Åberg M, Thålin C
Vaccines (Basel)
10
(3) - [2022-02-24; online 2022-02-24]
Affinity Proteomics Uppsala [Collaborative]
Autoimmunity and Serology Profiling [Collaborative]
PubMed
DOI
Crossref
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.
Havervall S,
Jernbom Falk A
,
Klingström J
, ...,
Nilsson P
, Thålin C
PLoS ONE
17
(1) e0262169 [2022-01-12; online 2022-01-12]
Autoimmunity and Serology Profiling [Collaborative]
PubMed
DOI
Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S
,
Ng H
,
Jernbom Falk A
, ...,
Hober S
,
Thålin C
J. Intern. Med.
291
(1) 72-80 [2022-01-00; online 2021-09-27]
Affinity Proteomics Uppsala [Service]
Autoimmunity and Serology Profiling [Collaborative]
PubMed
DOI
Crossref
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
Havervall S
, Marking U, Greilert-Norin N, ..., Åberg M,
Thålin C
EBioMedicine
70
(-) 103523 [2021-08-00; online 2021-08-12]
Affinity Proteomics Uppsala [Collaborative]
Autoimmunity and Serology Profiling [Collaborative]
PubMed
DOI
Crossref
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.
Hober S
, Hellström C,
Olofsson J
, ...,
Hedhammar M
,
Nilsson P
Clin Transl Immunology
10
(7) e1312 [2021-07-19; online 2021-07-19]
Autoimmunity and Serology Profiling [Technology development]
PubMed
DOI
Crossref
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.
Kvedaraite E,
Hertwig L
,
Sinha I
, ...,
Svensson M
,
Karolinska KI/K COVID-19 Study Group
Proc. Natl. Acad. Sci. U.S.A.
118
(6) e2018587118 [2021-02-09; online 2021-01-23]
Affinity Proteomics Stockholm [Service]
PubMed
DOI
Crossref
Innate lymphoid cell composition associates with COVID-19 disease severity.
García M
,
Kokkinou E
, Carrasco García A, ...,
Mjösberg J
, Karolinska KI/K COVID‐19 Study Group
Clin Transl Immunology
9
(12) e1224 [2020-12-14; online 2020-12-14]
Affinity Proteomics Stockholm [Service]
PubMed
DOI
Crossref
MAIT cell activation and dynamics associated with COVID-19 disease severity.
Parrot T
,
Gorin JB
,
Ponzetta A
, ...,
Strålin K
,
Sandberg JK
Sci Immunol
5
(51) - [2020-09-28; online 2020-09-30]
Affinity Proteomics Stockholm [Service]
PubMed
DOI
Crossref
Natural killer cell immunotypes related to COVID-19 disease severity.
Maucourant C
,
Filipovic I
,
Ponzetta A
, ...,
Björkström NK
, Karolinska COVID-19 Study Group
Sci Immunol
5
(50) eabd6832 [2020-08-21; online 2020-08-23]
Affinity Proteomics Stockholm [Service]
Bioinformatics Support for Computational Resources [Service]
SciLifeLab Data Centre
Publications
9.5.1